查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1623662

經顱磁刺激系統市場：依類型、應用、年齡層、最終用戶、地區、機會、預測，2018 年至 2032 年

Transcranial Magnetic Stimulation System Market Assessment, By Type, By Application, By Age Group, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 235 Pages | 商品交期: 3-5個工作天內

價格

全球經顱磁刺激系統市場規模預計將從2024 年的15.1 億美元成長到2032 年的32.5 億美元，在2025-2032 年預測期內的複合年增長率為10.05%。由於阿茲海默症、帕金森氏症和其他神經系統疾病的發病率不斷上升，全球經顱磁刺激系統市場預計將在預測期內繼續保持強勁成長。

經顱磁刺激系統是一種利用電磁場刺激特定腦部區域的非侵入性醫療設備。它主要用於治療神經和精神疾病，如重度憂鬱症（MDD）和強迫症（OCD），尤其是對常規治療沒有反應的患者。根據《柳葉刀神經病學》報導，神經系統疾病影響全球43%的人口。主要有帕金森氏症、新生兒腦病變、偏頭痛、阿茲海默症、糖尿病神經病變等。神經發育障礙和兒童疾病佔疾病負擔的近20%。非侵入性治療技術的進步以及對經顱磁刺激作為有效治療選擇的認識不斷提高，正在推動經顱磁刺激系統市場的成長。

本報告研究了全球經顱磁刺激系統市場，並概述了市場以及按類型、應用、年齡組、最終用戶、地理位置和公司概況劃分的主要市場趨勢。

目錄

第 1 章 專案範圍與定義

第 2 章 研究方法

第 3 章執行摘要

第 4 章2018 年至 2032 年全球經顱磁刺激系統市場展望
  • 市場規模分析及預測
  • 市佔率分析及預測
  • 2024 年市場地圖分析
    • 依類型
    • 依用途
    • 年齡組
    • 按最終用戶
    • 按地區

第 5 章2018 年至 2032 年北美經顱磁刺激系統市場展望 第 6 章2018 年至 2032 年歐洲經顱磁刺激系統市場展望 第 7 章 2018-2032 年亞太經顱磁刺激系統市場展望

第8章 南美洲經顱磁刺激系統市場展望，2018-2032

第9章 中東與非洲經顱磁刺激系統市場展望，2018-2032

第 10 章 需求與供給分析

第 11 章 價值鏈分析

第 12 章 波特五力分析

第 13 章 PESTLE 分析

第 14 章 定價分析

第 15 章 市場動態

第 16 章 市場趨勢與發展

第 17 章 監理架構與創新

第 18 章：專利格局

第 19 章案例研究

第 20 章 競爭格局

  • 五大市場領導者的競爭矩陣
  • 對前 5 名參賽者進行 SWOT 分析
  • 十大主要市場參與者的狀況
    • Nexstim Plc.
    • eNeura Inc.
    • Magstim, Inc.
    • TERUMO BCT, INC.
    • Arthrex, Inc.
    • neurocare group AG
    • Neuronetics, Inc.
    • Axilum Robotics SAS
    • Orchid Medical Centre
    • Medtronic plc.

第 21 章 策略建議

第 22 章 聯絡我們與免責聲明

Product Code: MX12500

Global transcranial magnetic stimulation system market is projected to witness a CAGR of 10.05% during the forecast period 2025-2032, growing from USD 1.51 billion in 2024 to USD 3.25 billion in 2032. The global transcranial magnetic stimulation system market is expected to keep growing at a robust pace during the forecast period, owing to the increasing prevalence of Alzheimer's disease, Parkinson's disease, and other neurological disorders.

A transcranial magnetic stimulation system is a non-invasive medical device that uses electromagnetic fields to stimulate specific brain areas. It is primarily used to treat neurological and psychiatric disorders such as major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), especially in patients who do not respond to conventional treatments. According to a Lancet neurology report, neurological conditions affect 43% of the world's population. The main participants include Parkinson's disease, neonatal encephalopathy, migraine, Alzheimer's disease, and diabetic neuropathy. Neurodevelopmental and pediatric disorders account for nearly 20% of the disease burden. Advancements in non-invasive therapeutic techniques and growing awareness of transcranial magnetic stimulation as an effective treatment option are driving the growth of the transcranial magnetic stimulation systems market. For instance, in March 2024, Neuronetics, Inc. announced the United States Food and Drug Administration clearance for its NeuroStar Advanced Therapy for use as an adjunct treatment for major depressive disorder in adolescents aged 15-21. NeuroStar becomes the first FDA-cleared TMS treatment for this age group, marking its fourth FDA clearance. With depression rates among adolescents rising, particularly post-COVID-19, NeuroStar offers a promising first-line treatment option supported by real-world data and response rates comparable to those in adults. This advancement has the potential to reshape how depression is treated in younger populations.

Increasing Prevalence of Mental Health Disorders Boosts Market Growth

The rising incidence of mental health disorders is a key growth driver for the global transcranial magnetic stimulation systems market, as depression, anxiety, epilepsy, Alzheimer's disease, and many other mental illnesses are on the rise across the globe. Additionally, demand has risen for innovative and non-invasive treatment options. TMS is gaining popularity as the best alternative in the treatment of patients who develop resistance to conventional therapies. The increasing burden of mental health disorders and the limitations of traditional treatments call for alternative therapies in the approach to treating these common disorders. This market is further supported by increasing acceptance among healthcare providers and patients. For instance, in January 2024, BrainsWay Ltd launched two feasibility studies to evaluate its new rotational field transcranial magnetic stimulation technology, focusing on stroke rehabilitation and OCD. The Deep TMS 360 system, which enhances neuron activation through a rotating electric field generated by two perpendicular coils, aims to overcome the limitations of traditional TMS systems.

Rising Awareness and Technological Advancement Drives Market Growth

Awareness and technological advantages are major growth drivers for the transcranial magnetic stimulation systems market. Increased awareness about the safety and effectiveness of TMS as a treatment option for various mental health diseases is creating high growth opportunities for TMS systems among healthcare professionals and patients. TMS is emerging as an alternative therapy for patients who do not respond to conventional treatments, and this has also driven the demand for TMS solutions. Additionally, technological innovations such as integrating artificial intelligence (AI) for more accurate treatments have further helped increase the prospects of the market. Advanced TMS systems now provide more customized and focused treatments, and patients may receive a wide range of disorders for treatment. Such developments, along with the increasing recognition of TMS as a promising treatment, are also driving market growth. For instance, in April 2024, Soterix Medical Inc. launched the MxN-GO EEG, a mobile, untethered system combining High-Definition transcranial Electrical Stimulation (HD-tES) and electroencephalogram system. Designed for mobile and natural environments, the lightweight, wire-free system offers 33 stimulation channels and 32 recording channels, providing high precision and targeted brain activity recording. Developed in collaboration with mBrainTrain LLC.

Adults Segment to Dominate the Transcranial Magnetic Stimulation System Market

The adult segment is expected to grow in the global transcranial magnetic stimulation system market, primarily due to this group's high prevalence of mental health disorders like depression and anxiety. The primary users of transcranial magnetic stimulation therapy are adults; the majority of them fall in the age group of 18-65 years. Growing prevalence of treatment-resistant depression, combined with increasing acceptance of non-invasive treatment procedures among adults. Furthermore, owing to the growing awareness about its safety and efficacy as an alternative to traditional treatments, and in consideration of favorable insurance coverage and accessibility to specialized care facilities, this segment enjoys dominance in the market.

For instance, in June 2024, BrainsWay Ltd. announced that the USFDA has granted for its Deep Transcranial Magnetic Stimulation (Deep TMS) system, now approved for the treatment of major depressive disorder in patients aged 22 to 86, extending the previous age limit of 68. BrainsWay Deep TMS is the first TMS treatment indicated for patients over 68 years old with MDD, including those with comorbid anxiety symptoms.

North America Dominates the Transcranial Magnetic Stimulation System Market

North America leads the market in the transcranial magnetic stimulation system because of the prevalence of mental health disorders in this region. Approximately 19.86% of United States adults live with a mental health condition, and 46% are expected to experience one during their lifetime. Over 20% of youth have faced a seriously debilitating mental condition, while around 5% of adults experience serious mental illness, driving demand for advanced treatments like TMS systems, increased adoption of advanced technologies in treatment, and established healthcare infrastructure. Moreover, the growing demand for non-invasive treatment options for conditions such as depression and anxiety, combined with government initiatives promoting mental health care, is growing the transcranial magnetic stimulation market. For instance, in January 2024, Magstim, Inc. received FDA clearance for its Horizon 3.0 system with StimGuide Pro, offering advanced TMS technology for treating depression and obsessive-compulsive conditions. The system features a user-friendly interface with Bluetooth anatomical mapping and precise treatment targeting through integrated camera technology. TMS uses electromagnetic coils to stimulate brain regions involved in mood control and depression.

Future Market Scenario (2025-2032F)

The global transcranial magnetic stimulation system market looks promising, aided by growing mental health awareness, technological advancements, and expanding therapeutic applications. The increased investment into research and development should unlock new opportunities for TMS as a treatment for increasingly broader neurological and psychiatric disorders. Significant growth potential as healthcare infrastructure improves and the demand for non-invasive treatment solutions grows. In addition, integrating artificial intelligence and machine learning to enhance the precision of treatment and patient outcomes will possibly reshape the transcranial magnetic stimulation system market. For instance, in August 2024, Neuronetics, Inc. announced an all-stock acquisition of Greenbrook TMS Inc., creating a vertically integrated organization focused on developing TMS technology. Neuronetics, based in Malvern, Pennsylvania, is known for its NeuroStar system, which uses a coil-based design for immediate depression treatment. Greenbrook, in addition to offering TMS therapy, provides Spravato nasal spray for depression, further expanding the combined company's portfolio in the neuro health market.

Key Players Landscape and Outlook

The transcranial magnetic stimulation system market is segmented into types and age-related patient treatment. The type segment is fragmented with numerous providers, while market players lead the type segment. Recent developments include advanced product launches, treatment center expansions, and strategic mergers and partnerships.

For instance, in May 2022, neurocare group AG announced the approval of its Apollo TMS system for depression treatment by the Therapeutic Goods Administration (TGA) in Australia. The system will be launched at the Royal Australian & New Zealand College of Psychiatry (RANZCP) Congress in Sydney. TMS has recently been included in the Medicare Benefits Schedule for patients with treatment-resistant depression under psychiatric care, further boosting the market potential for Apollo TMS in Australia.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Transcranial Magnetic Stimulation System Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Deep Transcranial Magnetic Stimulation
      • 4.2.1.2. Repetitive Transcranial Magnetic Stimulation
      • 4.2.1.3. Others
    • 4.2.2. By Application
      • 4.2.2.1. Epilepsy
      • 4.2.2.2. Depression
      • 4.2.2.3. Alzheimer's Disease
      • 4.2.2.4. Parkinson's Disease
      • 4.2.2.5. Others
    • 4.2.3. By Age Group
      • 4.2.3.1. Children
      • 4.2.3.2. Adults
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Clinics
      • 4.2.4.3. Ambulatory Surgical Centers
      • 4.2.4.4. Diagnostic Centers
      • 4.2.4.5. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Type
    • 4.3.2. By Application
    • 4.3.3. By Age Group
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Transcranial Magnetic Stimulation System Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Type
      • 5.2.1.1. Deep Transcranial Magnetic Stimulation
      • 5.2.1.2. Repetitive Transcranial Magnetic Stimulation
      • 5.2.1.3. Others
    • 5.2.2. By Application
      • 5.2.2.1. Epilepsy
      • 5.2.2.2. Depression
      • 5.2.2.3. Alzheimer's Disease
      • 5.2.2.4. Parkinson's Disease
      • 5.2.2.5. Others
    • 5.2.3. By Age Group
      • 5.2.3.1. Children
      • 5.2.3.2. Adults
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Clinics
      • 5.2.4.3. Ambulatory Surgical Centers
      • 5.2.4.4. Diagnostic Centers
      • 5.2.4.5. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Transcranial Magnetic Stimulation System Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Type
          • 5.3.1.2.1.1. Deep Transcranial Magnetic Stimulation
          • 5.3.1.2.1.2. Repetitive Transcranial Magnetic Stimulation
          • 5.3.1.2.1.3. Others
        • 5.3.1.2.2. By Application
          • 5.3.1.2.2.1. Epilepsy
          • 5.3.1.2.2.2. Depression
          • 5.3.1.2.2.3. Alzheimer's Disease
          • 5.3.1.2.2.4. Parkinson's Disease
          • 5.3.1.2.2.5. Others
        • 5.3.1.2.3. By Age Group
          • 5.3.1.2.3.1. Children
          • 5.3.1.2.3.2. Adults
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals
          • 5.3.1.2.4.2. Clinics
          • 5.3.1.2.4.3. Ambulatory Surgical Centers
          • 5.3.1.2.4.4. Diagnostic Centers
          • 5.3.1.2.4.5. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Transcranial Magnetic Stimulation System Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Transcranial Magnetic Stimulation System Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Transcranial Magnetic Stimulation System Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Transcranial Magnetic Stimulation System Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Clinical Trials
  • 17.2. Regulatory Approvals
  • 17.3. Innovations

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Nexstim Plc.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. eNeura Inc.
    • 20.3.3. Magstim, Inc.
    • 20.3.4. TERUMO BCT, INC.
    • 20.3.5. Arthrex, Inc.
    • 20.3.6. neurocare group AG
    • 20.3.7. Neuronetics, Inc.
    • 20.3.8. Axilum Robotics SAS
    • 20.3.9. Orchid Medical Centre
    • 20.3.10. Medtronic plc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 3. Global Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 4. Global Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 5. Global Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Transcranial Magnetic Stimulation System Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 9. North America Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 10. North America Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 11. North America Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Transcranial Magnetic Stimulation System Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 15. United States Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 16. United States Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 17. United States Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 20. Canada Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 21. Canada Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 22. Canada Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 25. Mexico Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 26. Mexico Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 27. Mexico Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 30. Europe Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 31. Europe Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 32. Europe Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Transcranial Magnetic Stimulation System Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 36. Germany Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 37. Germany Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 38. Germany Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 41. France Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 42. France Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 43. France Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 46. Italy Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 47. Italy Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 48. Italy Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 51. United Kingdom Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 52. United Kingdom Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 53. United Kingdom Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 56. Russia Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 57. Russia Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 58. Russia Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 61. Netherlands Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 62. Netherlands Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 63. Netherlands Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 66. Spain Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 67. Spain Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 68. Spain Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 71. Turkey Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 72. Turkey Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 73. Turkey Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 76. Poland Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 77. Poland Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 78. Poland Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 81. South America Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 82. South America Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 83. South America Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Transcranial Magnetic Stimulation System Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 87. Brazil Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 88. Brazil Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 89. Brazil Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 92. Argentina Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 93. Argentina Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 94. Argentina Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 97. Asia-Pacific Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 98. Asia-Pacific Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 99. Asia-Pacific Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Transcranial Magnetic Stimulation System Market Share (%), By Country, 2018-2032F
  • Figure 101. India Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 103. India Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 104. India Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 105. India Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 108. China Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 109. China Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 110. China Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 113. Japan Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 114. Japan Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 115. Japan Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 118. Australia Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 119. Australia Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 120. Australia Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 123. Vietnam Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 124. Vietnam Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 125. Vietnam Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 128. South Korea Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 129. South Korea Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 130. South Korea Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 133. Indonesia Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 134. Indonesia Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 135. Indonesia Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 138. Philippines Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 139. Philippines Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 140. Philippines Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 143. Middle East & Africa Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 144. Middle East & Africa Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 145. Middle East & Africa Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Transcranial Magnetic Stimulation System Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 149. Saudi Arabia Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 150. Saudi Arabia Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 151. Saudi Arabia Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 154. UAE Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 155. UAE Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 156. UAE Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Transcranial Magnetic Stimulation System Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Transcranial Magnetic Stimulation System Market Share (%), By Type, 2018-2032F
  • Figure 159. South Africa Transcranial Magnetic Stimulation System Market Share (%), By Application, 2018-2032F
  • Figure 160. South Africa Transcranial Magnetic Stimulation System Market Share (%), By Age Group, 2018-2032F
  • Figure 161. South Africa Transcranial Magnetic Stimulation System Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024